tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

ACADIA Pharmaceuticals Inc

ACAD
Add to Watchlist
21.230USD
-0.010-0.05%
Close 11-06 16:00（ET）
3.66BMarket Cap
9.53P/E TTM

ACADIA Pharmaceuticals Inc

21.230
-0.010-0.05%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

ACAD Financials

See ACADIA Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
3.66B
Dividend TTM
0.00
P/E TTM
9.53
EPS TTM
2.23
Revenue
1.07B
Net Profit
226.45M
ROE
37.32%
ROA
27.44%
ACADIA Pharmaceuticals Inc Earnings Date
Latest Release
Nov 4, 2026
EPS / Forecast
0.31/0.20
Revenue / Forecast
342.29M/332.47M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-27.04%0.31
15.53%0.18
-81.26%0.02
86.54%1.61
115.36%0.43
-21.22%0.16
13.31%0.11
210.62%0.86
149.74%0.20
2857.18%0.20
137.89%0.10
207.88%0.28
---0.40
--0.01
---0.27
---0.26
---1.08
----
----
----
Revenue
22.85%342.29M
16.40%307.96M
9.72%268.06M
9.39%283.99M
11.27%278.63M
9.34%264.57M
18.70%244.32M
12.36%259.60M
18.28%250.40M
46.44%241.96M
73.75%205.83M
69.27%231.04M
61.96%211.70M
22.79%165.24M
2.59%118.46M
4.38%136.49M
-0.68%130.71M
16.79%134.56M
8.37%115.47M
8.06%130.76M
Net Profit
-25.43%53.52M
18.13%31.50M
-80.84%3.64M
90.32%273.57M
119.07%71.78M
-20.14%26.67M
14.69%18.99M
213.87%143.74M
150.27%32.77M
2897.22%33.39M
138.48%16.55M
209.76%45.80M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
3.18%-41.73M
-88.03%-27.18M
22.47%-34.01M
-70.14%-113.06M
35.45%-43.09M
Net Margin
-39.30%15.64%
1.48%10.23%
-82.54%1.36%
73.98%96.33%
96.88%25.76%
-26.96%10.08%
-3.38%7.77%
179.34%55.37%
142.50%13.09%
1946.79%13.80%
122.15%8.04%
164.84%19.82%
---30.79%
--0.67%
---36.32%
---30.57%
---45.77%
----
----
----
Gross Margin
-2.69%89.75%
-1.47%90.81%
-0.98%90.75%
-0.91%90.77%
-0.26%92.23%
-0.33%92.16%
3.16%91.65%
-0.71%91.60%
-0.67%92.47%
-3.16%92.47%
-9.88%88.85%
-6.08%92.26%
--93.09%
--95.49%
--98.59%
--98.23%
--97.96%
----
----
----
Income Statement
Revenue
22.85%342.29M
16.40%307.96M
9.72%268.06M
9.39%283.99M
11.27%278.63M
9.34%264.57M
18.70%244.32M
12.36%259.60M
18.28%250.40M
46.44%241.96M
73.75%205.83M
69.27%231.04M
61.96%211.70M
22.79%165.24M
2.59%118.46M
4.38%136.49M
-0.68%130.71M
16.79%134.56M
8.37%115.47M
8.06%130.76M
Operating profit
100.58%71.72M
16.87%37.84M
-123.93%-4.62M
148.87%17.39M
12.99%35.76M
6.36%32.37M
26.82%19.29M
-80.00%6.99M
154.77%31.64M
902.21%30.44M
128.39%15.21M
175.86%34.94M
-87.18%-57.78M
109.02%3.04M
52.59%-53.58M
-3.15%-46.06M
-101.73%-30.87M
23.01%-33.65M
-69.26%-113.02M
33.51%-44.66M
Net Profit
-25.43%53.52M
18.13%31.50M
-80.84%3.64M
90.32%273.57M
119.07%71.78M
-20.14%26.67M
14.69%18.99M
213.87%143.74M
150.27%32.77M
2897.22%33.39M
138.48%16.55M
209.76%45.80M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
3.18%-41.73M
-88.03%-27.18M
22.47%-34.01M
-70.14%-113.06M
35.45%-43.09M
Balance Sheet
Current assets
17.84%1.27B
27.48%1.22B
25.84%1.10B
13.19%1.06B
36.55%1.08B
31.78%960.55M
28.97%870.94M
52.29%938.32M
57.92%788.28M
47.96%728.92M
34.29%675.30M
21.30%616.13M
-4.29%499.17M
-7.49%492.63M
-7.26%502.85M
-17.79%507.94M
-18.62%521.55M
-17.53%532.52M
-19.55%542.22M
-13.91%617.82M
Total current liabilities
-6.83%332.22M
9.52%361.44M
0.99%305.52M
-29.82%277.11M
3.67%356.58M
-2.32%330.02M
-8.49%302.53M
55.31%394.87M
64.09%343.94M
79.76%337.85M
47.39%330.60M
102.38%254.25M
79.81%209.60M
59.70%187.94M
87.54%224.30M
30.77%125.63M
32.14%116.57M
23.45%117.68M
9.35%119.60M
-9.34%96.07M
Total assets
34.82%1.79B
42.21%1.74B
41.76%1.61B
31.69%1.56B
36.23%1.33B
34.07%1.23B
32.42%1.13B
58.59%1.19B
54.44%976.87M
42.21%914.10M
30.49%855.10M
27.41%748.96M
4.99%632.54M
4.90%642.77M
4.97%655.30M
-16.04%587.81M
-16.05%602.49M
-15.41%612.77M
-17.34%624.25M
-10.54%700.12M
Total liabilities
-1.65%406.66M
8.21%436.29M
-2.71%357.16M
-25.97%336.81M
3.46%413.50M
1.45%403.17M
-6.12%367.13M
43.43%454.96M
47.83%399.69M
60.91%397.40M
39.14%391.06M
69.27%317.20M
52.92%270.37M
38.81%246.98M
56.61%281.05M
17.69%187.40M
17.31%176.81M
11.48%177.92M
3.39%179.45M
2.33%159.23M
Total equity
51.26%1.39B
58.88%1.31B
63.10%1.25B
67.49%1.23B
58.92%917.27M
59.16%822.38M
64.91%765.24M
69.72%732.79M
59.37%577.18M
30.55%516.70M
23.99%464.04M
7.83%431.75M
-14.92%362.17M
-8.98%395.79M
-15.86%374.26M
-25.97%400.41M
-24.92%425.69M
-23.01%434.85M
-23.52%444.80M
-13.73%540.89M
Cash Flow Statement
Net operating income
-84.52%11.50M
57.58%100.78M
67.20%33.98M
-220.68%-48.73M
17.46%74.29M
155.69%63.96M
-30.11%20.32M
-52.71%40.38M
207.28%63.25M
205.00%25.01M
262.15%29.08M
457.97%85.39M
-8009.35%-58.95M
162.48%8.20M
76.51%-17.93M
-3.17%-23.85M
95.74%-727.00K
48.18%-13.13M
-26.90%-76.33M
15.89%-23.12M
Net investment
-8.57%-86.15M
80.30%-8.53M
153.43%66.28M
-145.74%-55.87M
3.77%-79.35M
22.95%-43.29M
-783.60%-124.05M
35301.73%122.15M
-341.74%-82.46M
71.08%-56.19M
-107.29%-14.04M
98.04%-347.00K
120.91%34.11M
-248.20%-194.28M
46.57%192.52M
-124.81%-17.75M
109.88%15.44M
-224.27%-55.80M
325.38%131.34M
161.17%71.55M
Net financing
25.98%11.87M
-34.23%10.49M
130.20%4.23M
1051.14%22.67M
3416.04%9.42M
347.57%15.96M
76.22%1.84M
-63.77%1.97M
-97.90%268.00K
-34.92%3.56M
-28.85%1.04M
236.68%5.43M
4342.86%12.75M
42.99%5.48M
-40.58%1.47M
-63.02%1.61M
-73.08%287.00K
-23.46%3.83M
-68.07%2.47M
-75.92%4.37M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 1.07B, with a year-on-year change of 957.80M.

What are the current assets of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its current assets were 1.06B, with a year-on-year change of 13.19.

What are the total assets of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total assets of ACADIA Pharmaceuticals Inc were 1.56B, with a year-on-year change of 31.69.

What are the total liabilities of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of ACADIA Pharmaceuticals Inc were 336.81M, with a year-on-year change of -25.97.

What is the total equity of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total equity of ACADIA Pharmaceuticals Inc was 1.23B, with a year-on-year change of 67.49.

What is the net operating income of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net operating income of ACADIA Pharmaceuticals Inc was 104.81M, with a year-on-year change of 24.36.

What is the net investment of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net investment of ACADIA Pharmaceuticals Inc was -302.56M, with a year-on-year change of -890.78.

What is the net financing of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net financing of ACADIA Pharmaceuticals Inc was 49.88M, with a year-on-year change of 628.75.

What is the Earnings Per Share (EPS) of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.32, with a year-on-year change of 69.96.

What is the net income of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net income was 391.00M, with a year-on-year change of 72.66.

What is the net margin of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 36.49, with a year-on-year change of 54.34.

What is the gross margin of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 91.69, with a year-on-year change of 0.26.

What is the Return on Equity (ROE) of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 39.89, with a year-on-year change of 2.58.

What is the Return on Assets (ROA) of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 28.42, with a year-on-year change of 21.51.

What is the operating profit of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 104.81M, with a year-on-year change of 24.36.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy